Concepedia

Publication | Closed Access

BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer

38

Citations

26

References

2020

Year

References

YearCitations

Page 1